References
- Jemal ACM, Ward E, Thun MJ. Cancer occurrence. Methods Mol Biol. 2009;471:3–29.
- Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71–96.
- Chen CZLL, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303(5654):83–86.
- Eis PSTW, Sun L, Chadburn A, et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA. 2005;102(10):3627–3632.
- Brennecke JHD, Stark A, Russell RB, et al. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell. 2003;113(1):25–36.
- He LTJ, Hemann MT, Hernando-Monge E, et al. A microRNA polycistron as a potential human oncogene. Nature. 2005;435(7043):828–833.
- O’Donnell KAWE, Zeller KI, Dang CV, et al. c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 2005;435(7043):839–843.
- Michael MZOCS, Van Holst Pellekaan NG, Young GP, et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res. 2003;1(12):882–891.
- Akao YNY, Naoe T. Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull. 2006;29(5):903–906.
- Bandrés ECE, Agirre X, Malumbres R, et al. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer. 2006;5:29.
- Dong YYJ, Ng SS. MicroRNA dysregulation as a prognostic biomarker in colorectal cancer. Cancer Manag Res. 2014;6:405–422.
- Goel AKA, Aggarwal BB. Curcumin as “Curecumin”: from kitchen to clinic. Biochem Pharmacol. 2008;75(4):787–809.
- Panahi Y, Badeli R, Karami GR, et al. Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder. Phytotherapy Res. 2015;29(1):17–21.
- Panahi Y, Khalili N, Hosseini MS, et al. Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial. Complementary Therapies Med. 2014;22(5):851–857.
- Panahi Y, Saadat A, Beiraghdar F, et al. Antioxidant effects of bioavailability-enhanced curcuminoids in patients with solid tumors: A randomized double-blind placebo-controlled trial. J Functional Foods. 2014;6(1):615–622.
- Panahi Y, Saadat A, Beiraghdar F, et al. Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: A randomized double-blind placebo-controlled trial. Phytotherapy Res. 2014;28(10):1461–1467.
- Sahebkar A. Are curcuminoids effective c-reactive protein-lowering agents in clinical practice? evidence from a meta-analysis. Phytotherapy Research, 2014;28(5):633–642. doi:10.1002/ptr.5045
- Sahebkar A. Curcuminoids for the management of hypertriglyceridaemia. Nature Reviews Cardiology, 2014;11(2). doi:10.1038/nrcardio.2013.140-c1
- Uzzan BBR. Is Curcumin a Chemopreventive Agent for Colorectal Cancer? Curr Colorectal Cancer Rep. 2016;12:35–41.
- Gupta SCPS, Koh W, Aggarwal BB. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol. 2012;39(3):283–299.
- Ramasamy TSAA, Myint HH, Thiagarajah S, et al. Targeting colorectal cancer stem cells using curcumin and curcumin analogues: insights into the mechanism of the therapeutic efficacy. Cancer Cell Int. 2015;15:96.
- Mudduluru GG-WJ, Muppala S, Asangani IA, et al. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci Rep. 2011;31(3):185–197.
- Roy SYY, Padhye SB, Sarkar FH, et al. Difluorinated-curcumin (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21. PLoS One. 2013;8(7):e68543.
- Misso G, Di Martino MT, De Rosa G, et al. Mir-34: a new weapon against cancer? Mol Ther Nucleic Acids. 2014;3:e194.
- Roy SLE, Majumdar AP, Sarkar FH. Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF. J Hematol Oncol. 2012;19(5):58.
- Noratto GDJI, Safe S, Angel-Morales G, et al. The drug resistance suppression induced by curcuminoids in colon cancer SW-480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis. Mol Nutr Food Res. 2013;57(9):1638–1648.
- Gandhy SUKK, Larsen L, Rosengren RJ, et al. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs. BMC Cancer. 2012;12:564.